Levine Cancer Institute Approach to Pandemic Care of Patients With Cancer.

Surgical Decision Making in the Era of COVID-19: A New Set of Rules.

Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.

Corrigendum to "Phase III trials in ovarian cancer: The evolving landscape of front line therapy" [Gynecol. Oncol. 153 (2019) 436-444].

The current state of molecular testing in the treatment of patients with solid tumors, 2019.

When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey.

Phase III trials in ovarian cancer: The evolving landscape of front line therapy.

Complete surgical resection of isolated recurrent high-grade epithelial ovarian cancer in highly selected patients without chemotherapy is associated with an excellent outcome.

Author's Reply.